Sage Therapeutics Inc (SAGE)
11.90
-0.44
(-3.57%)
USD |
NASDAQ |
May 10, 16:00
11.89
-0.01
(-0.08%)
After-Hours: 20:00
Sage Therapeutics Revenue (TTM): 91.06M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 91.06M |
| December 31, 2023 | 86.46M |
| September 30, 2023 | 11.35M |
| June 30, 2023 | 10.37M |
| March 31, 2023 | 9.399M |
| December 31, 2022 | 7.687M |
| September 30, 2022 | 6.464M |
| June 30, 2022 | 6.165M |
| March 31, 2022 | 6.307M |
| December 31, 2021 | 6.308M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.114B |
| June 30, 2021 | 1.114B |
| March 31, 2021 | 1.113B |
| December 31, 2020 | 1.114B |
| September 30, 2020 | 6.974M |
| June 30, 2020 | 8.905M |
| March 31, 2020 | 8.689M |
| December 31, 2019 | 6.868M |
| September 30, 2019 | 5.181M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.181M
Minimum
Sep 2019
1.114B
Maximum
Dec 2020
249.15M
Average
8.905M
Median
Jun 2020
Revenue (TTM) Benchmarks
| Biogen Inc | 9.663B |
| Vanda Pharmaceuticals Inc | 192.64M |
| Ligand Pharmaceuticals Inc | 118.31M |
| ADMA Biologics Inc | 258.22M |
| Finch Therapeutics Group Inc | -- |